Literature DB >> 8139611

Increased levels of lipid hydroperoxides in the parkinsonian substantia nigra: an HPLC and ESR study.

D T Dexter1, A E Holley, W D Flitter, T F Slater, F R Wells, S E Daniel, A J Lees, P Jenner, C D Marsden.   

Abstract

Previous studies examining the involvement of oxidative stress in the substantia nigra in Parkinson's disease have measured terminal products of lipid peroxidation or the function of antioxidant defense systems. We report a more specific early marker of lipid peroxidation, lipid hydroperoxides, in a high-performance liquid chromatography (HPLC) and electron spin resonance (ESR) investigation. HPLC-chemiluminescent detection revealed two classes of lipid hydroperoxides in brain tissue extracts--free fatty acid hydroperoxides and cholesterol lipid hydroperoxides. Only cholesterol lipid hydroperoxides were consistently detected in all tissue extracts. Cholesterol lipid hydroperoxides had a 10-fold increase in the Parkinson's disease substantia nigra compared to control subjects. ESR detection of radical degradation products, including those of lipid hydroperoxides, in nigral homogenates incubated with the spin trap N-t-butyl-alpha-phenyl nitrone (PBN) showed a marked variation in ESR signal between tissues. Despite the increased levels of lipid hydroperoxides in parkinsonian substantia nigra, there was no overall difference in ESR signal intensity between nigral tissues from controls and from patients with Parkinson's disease. The increased levels of an early component of the peroxidation chain in substantia nigra in Parkinson's disease support the hypothesis of a continuous toxic process involving oxygen radical activity. However, using previously frozen tissue, ESR evidence for increased radical formation could not be demonstrated.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8139611     DOI: 10.1002/mds.870090115

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  82 in total

Review 1.  NO synthase and NO-dependent signal pathways in brain aging and neurodegenerative disorders: the role of oxidant/antioxidant balance.

Authors:  V Calabrese; T E Bates; A M Stella
Journal:  Neurochem Res       Date:  2000-10       Impact factor: 3.996

2.  Experimental strategy to identify genes susceptible to oxidative stress in nigral dopaminergic neurons.

Authors:  Myung S Yoo; Hibiki Kawamata; Dae J Kim; Hong S Chun; Jin H Son
Journal:  Neurochem Res       Date:  2004-06       Impact factor: 3.996

Review 3.  Mitochondrial dysfunction and oxidative damage in Alzheimer's and Parkinson's diseases and coenzyme Q10 as a potential treatment.

Authors:  M Flint Beal
Journal:  J Bioenerg Biomembr       Date:  2004-08       Impact factor: 2.945

Review 4.  Reactive oxygen species in the regulation of synaptic plasticity and memory.

Authors:  Cynthia A Massaad; Eric Klann
Journal:  Antioxid Redox Signal       Date:  2010-10-28       Impact factor: 8.401

5.  Strategies for the protection of dopaminergic neurons against neurotoxicity.

Authors:  M Gerlach; K L Double; M B Youdim; P Riederer
Journal:  Neurotox Res       Date:  2000       Impact factor: 3.911

6.  Neuroprotective and neurorestorative strategies for neuronal injury.

Authors:  M F Beal; T Palomo; R M Kostrzewa; T Archer
Journal:  Neurotox Res       Date:  2000       Impact factor: 3.911

Review 7.  Oxidative damage to macromolecules in human Parkinson disease and the rotenone model.

Authors:  Laurie H Sanders; J Timothy Greenamyre
Journal:  Free Radic Biol Med       Date:  2013-01-15       Impact factor: 7.376

8.  Glia maturation factor deficiency suppresses 1-methyl-4-phenylpyridinium-induced oxidative stress in astrocytes.

Authors:  Mohammad Moshahid Khan; Duraisamy Kempuraj; Smita Zaheer; Asgar Zaheer
Journal:  J Mol Neurosci       Date:  2014-01-16       Impact factor: 3.444

9.  Microglial activation and dopaminergic cell injury: an in vitro model relevant to Parkinson's disease.

Authors:  W Le; D Rowe; W Xie; I Ortiz; Y He; S H Appel
Journal:  J Neurosci       Date:  2001-11-01       Impact factor: 6.167

10.  Astrocytic dynamin-like protein 1 regulates neuronal protection against excitotoxicity in Parkinson disease.

Authors:  Jake G Hoekstra; Travis J Cook; Tessandra Stewart; Hayley Mattison; Max T Dreisbach; Zachary S Hoffer; Jing Zhang
Journal:  Am J Pathol       Date:  2014-12-04       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.